OmniAb, Inc. — Earnings Quality Grade F
OABI · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO surged by 72 days (73 → 145)
Small-cap context: DSO swings on a small revenue base are more often quarterly customer-mix effects than red flags.
AR outpaced revenue for 2 consecutive years
Revenue -29.3%, CFFO 8.1%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth -69.9% vs revenue -29.3%. Normal
SG&A/Gross Profit = 159.1%, exceeds 70%
Gross margin 98.4%, change -1.6pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF is negative ($-0.0B)
Accruals ratio = -9.4%. Low accruals
Cash $0.1B covers debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.2B = 78% of equity. Over 50%
Debt/EBITDA = -0.4x. Healthy
Other assets -29.9% vs revenue -29.3%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
Goodwill+Intangibles change -6% YoY. Normal
Manipulation Score
M-Score = -2.39 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor OABI continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25